The DOI matches its Crossref record; 115 of the 117 references it cites were found in a registry or an index.
Screening for Pancreatic Cancer: Why, How, and Who?
Open accessAbstract
In Brief Pancreatic cancer is the fourth most common cause of cancer mortality in the United States, with 5-year survival rates for patients with resectable tumors ranging from 15% to 20%. However, most patients presenting with distant metastases, are not resectable, and have a 5-year survival rate of close to 0%. This demonstrates a need for improved screening to identify pancreatic cancer while the tumor is still localized and amenable to surgical resection. Studies of patients with pancreatic tumors incidentally diagnosed demonstrate longer median survival than tumors discovered only when the patient is symptomatic, suggesting that early detection may improve outcome. Recent evidence from genomic sequencing indicates a 15-year interval for genetic progression of pancreatic cancer from initiation to the metastatic stage, suggesting a sufficient window for early detection. Still, many challenges remain in implementing effective screening. Early diagnosis of pancreatic cancer relies on developing screening methodologies with highly sensitive and specific biomarkers and imaging modalities. It also depends on a better understanding of the risk factors and natural history of the disease to accurately identify high-risk groups that would be best served by screening. This review summarizes our current understanding of the biology of pancreatic cancer relevant to methods available for screening. At this time, given the lack of proven benefit in this disease, screening efforts should probably be undertaken in the context of prospective trials. Pancreatic adenocarcinoma is a largely fatal disease with increased survival for patients with localized disease compared with those with distant metastases. A critical evaluation of early detection strategies is presented in light of results from more common cancers. Improved outcomes may be attained by focusing screening on high-risk groups; however, these efforts are as yet unproven.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Screening individuals in high-risk groups increases the rate of detection and reduces false-positive results.8”
From Early detection of pancreatic cancer (2020) · cites this paper as [8]
In the citing paper
“Similarly, incidentally diagnosed pancreatic ductal adenocarcinoma (ie, discovered serendipitously while screening or checking for other diseases) is associated with longer median survival than pancreatic ductal adenocarcinoma that is diagnosed when patients have symptoms.8”
From Early detection of pancreatic cancer (2020) · cites this paper as [8]
In the citing paper
“Patients diagnosed with stage 1 disease experience longer survival times than patients diagnosed with disease at more advanced stages.8”
From Early detection of pancreatic cancer (2020) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gerçel-Taylor, Ç. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,333
RetractedFOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P. G., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,895
Hospital Volume and Surgical Mortality in the United States
Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012337 · Cited by 5,001
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Siegel, R. L., Ward, E., Brawley, O. W., & Jemal, A. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,075
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,220
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,784
Flagged first, then by citations
2 of the 117 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection
Raimondi, S., Lowenfels, A. B., Morselli‐Labate, A. M., Maisonneuve, P., & Pezzilli, R. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.02.007 · Cited by 653
Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer
Huang, J., Lok, V., Ngai, C. H., Zhang, L., Yuan, J., Lao, X. Q., Ng, K. K., Chong, C. C. N., Zheng, Z., & Wong, M. C. S. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.007 · Cited by 539
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
Hidalgo, M. M., Cascinu, S., Kleeff, J. H., Labianca, R., Löhr, M. J., Neoptolemos, J. P., Real, F. X., Laethem, J. V., & Heinemann, V. (2014) · Pancreatology · doi:10.1016/j.pan.2014.10.001 · Cited by 530
Orth, M., Metzger, P., Gerum, S., Mayerle, J. V., Schneider, G., Belka, C., Schnurr, M., & Lauber, K. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1345-6 · Cited by 523
Early detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482
Imaging diagnosis of pancreatic cancer: A state-of-the-art review
Lee, E. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7864 · Cited by 401
The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates
Poruk, K. E., Gay, D., Brown, K. S., Mulvihill, J. D., Boucher, K. M., Scaife, C. L., Firpo, M. A., & Mulvihill, S. J. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313030003 · Cited by 396
Self-citationPancreatic Cancer: Yesterday, Today and Tomorrow
Ansari, D., Tingstedt, B., Andersson, B., Holmquist, F., Sturesson, C., Williamsson, C., Sasor, A., Borg, D., Bauden, M. P., & Andersson, R. E. (2016) · Future Oncology · doi:10.2217/fon-2016-0010 · Cited by 399
The enhancement of glycolysis regulates pancreatic cancer metastasis
Yang, J., Ren, B., Yang, G., Wang, H., Chen, G., You, L., Zhang, T., & Zhao, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03278-z · Cited by 347
Current status and progress of pancreatic cancer in China
Lin, Q. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i26.7988 · Cited by 285
Prospects for point-of-care pathogen diagnostics using surface-enhanced Raman scattering (SERS)
Granger, J. H., Schlotter, N. E., Crawford, A. C., & Porter, M. D. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00828j · Cited by 268
Early detection of pancreatic cancer: Where are we now and where are we going?
Zhou, B., Xu, J., Cheng, Y., Gao, J., Hu, S., Wang, L., & Zhan, H. (2017) · International Journal of Cancer · doi:10.1002/ijc.30670 · Cited by 218
Hadano, N., Murakami, Y., Uemura, K., Hashimoto, Y., Kondo, N., Nakagawa, N., Sueda, T., & Hiyama, E. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.175 · Cited by 173
miR-1246 and miR-4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer
Machida, T., Tomofuji, T., Maruyama, T., Yoneda, T., Ekuni, D., Azuma, T., Miyai, H., Mizuno, H., Kato, H., Tsutsumi, K., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5021 · Cited by 170
Nakamura, K., Zhu, Z., Roy, S., Jun, E., Han, H., Muñoz, R. M., Nishiwada, S., Sharma, G. G., Cridebring, D., Zenhausern, F., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.090 · Cited by 174
Bergquist, J. R., Puig, C. A., Shubert, C. R., Groeschl, R. T., Habermann, E. B., Kendrick, M. L., Nagorney, D. M., Smoot, R. L., Farnell, M. B., & Truty, M. J. (2016) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2016.02.009 · Cited by 159
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Poruk, K. E., Valero, V., Saunders, T., Blackford, A. L., Griffin, J. F., Poling, J., Hruban, R. H., Anders, R. A., Herman, J. M., Zheng, L., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001600 · Cited by 155
Self-citationSalivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer
Xie, Z., Chen, X., Li, J., Guo, Y., Li, H., Pan, X., Jiang, J., Liu, H., & Wu, B. (2016) · Oncotarget · doi:10.18632/oncotarget.8323 · Cited by 150
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer
Ji, S., Qin, Y., Shi, S., Liu, X., Hu, H., Zhou, H., Gao, J., Zhang, B., Xu, W., Liu, J., et al. (2015) · Cell Research · doi:10.1038/cr.2015.30 · Cited by 137
Metabolism addiction in pancreatic cancer
Blum, R., & Kloog, Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.38 · Cited by 138
Early detection of pancreatic cancer using DNA-based molecular approaches
Singhi, A. D., & Wood, L. D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00470-0 · Cited by 127
Advances in pancreatic cancer biomarkers
Hasan, S. M., Jacob, R., Manne, U., & Paluri, R. K. (2019) · Oncology Reviews · doi:10.4081/oncol.2019.410 · Cited by 124
Zhao, L., Sun, H., Kong, H., Chen, Z., Chen, B., & Zhou, M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479990 · Cited by 111
Gou, S., Cui, P., Li, X., Shi, P., Liu, T., & Wang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063969 · Cited by 109
Wang, Y., Zhao, C., Chang, L., Jia, R., Liu, R., Zhang, Y., Gao, X., Li, J., Chen, R., Xia, X., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.003 · Cited by 101
Zafar, S., Hafeez, A., Shah, H., Mutiullah, I., Ali, A., Khan, K., Figueroa‐González, G., Reyes‐Hernández, O. D., Granados, L. I. Q., Peña‐Corona, S. I., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-03003-6 · Cited by 123
Granger, J. H., Granger, M. C., Firpo, M. A., Mulvihill, S. J., & Porter, M. D. (2012) · The Analyst · doi:10.1039/c2an36128k · Cited by 97
Self-citationClinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
Riva, F., Dronov, O. I., Khomenko, D. I., Huguet, F., Louvet, C., Mariani, P., Stern, M., Lantz, O. J., Proudhon, C., Pierga, J., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.006 · Cited by 97
Gall, T., Jacob, J., Frampton, A. E., Krell, J., Kyriakides, C., Castellano, L., Stebbing, J., & Jiao, L. R. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.3643 · Cited by 92
Prostate-specific antigen (PSA) as a possible biomarker in non-prostatic cancer: A review
Pérez-Ibave, D. C., Burciaga-Flores, C. H., & Elizondo-Riojas, M.-Á. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.03.009 · Cited by 97
Honda, K., Kobayashi, M., Okusaka, T., Rinaudo, J. A., Huang, Y., Marsh, T. L., Sanada, M., Sasajima, Y., Nakamori, S., Shimahara, M., et al. (2015) · Scientific Reports · doi:10.1038/srep15921 · Cited by 89
Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer
Toyama, Y., Hotta, M., Motoi, F., Takanami, K., Minamimoto, R., & Takase, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-73237-3 · Cited by 75
Chai, X.-Q., Chu, H., Yang, X., Meng, Y.-P., Shi, P., & Gou, S. (2015) · Scientific Reports · doi:10.1038/srep14404 · Cited by 74
The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
Li, X., Li, T., Liu, Z., Gou, S., & Wang, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-06207-x · Cited by 74
Qiu, J., Yang, G., Feng, M., Zheng, S., Cao, Z., You, L., Zheng, L., Zhang, T., & Zhao, Y. (2018) · Molecular Cancer · doi:10.1186/s12943-017-0755-z · Cited by 77
Kim, V. M., Blair, A. B., Lauer, P., Foley, K., Che, X., Soares, K. C., Xia, T., Muth, S. T., Kleponis, J., Armstrong, T. D., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0601-5 · Cited by 71
Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis
Creemers, A., Krausz, S., Strijker, M., van der Wel, M. J., Soer, E. C., Reinten, R. J. A., Besselink, M. G., Wilmink, J. W., van de Vijver, M. J., van Noesel, C. J. M., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.08.002 · Cited by 69
Lou, C., Zhao, J., Gu, Y., Li, Q., Tang, S., Wu, Y., Tang, J., Zhang, C., Li, Z., & Zhang, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29288 · Cited by 68
Yamazaki, H., Tauchi, S., Wang, J., Dohke, M., Hanawa, N., Kodama, Y., Katanuma, A., Saisho, Y., Kamitani, T., Fukuhara, S., et al. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01683-x · Cited by 60
Lesmana, C. R. A., Gani, R. A., & Lesmana, L. A. (2017) · JGH Open · doi:10.1002/jgh3.12032 · Cited by 58
Chen, W., Butler, R. K., Lustigova, E., Chari, S. T., & Wu, B. U. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06139-z · Cited by 62
Arginine metabolism: a potential target in pancreatic cancer therapy
Yang, J., Wang, C., Qiu, J., Ren, B., & You, L. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001216 · Cited by 56
Li, X., Guo, R., Lu, J., Chen, T., & Qian, X. (2023) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2023.3236162 · Cited by 56
Zhang, J., Zhang, L., Li, C., Yang, C., Li, L., Song, S., Wu, H., Liu, F., Wang, L., & Gu, J. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0360-6 · Cited by 58
Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma
Sharma, G. G., Okada, Y., Hoff, D. D. V., & Goel, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.001 · Cited by 54
Yao, L., Zhang, Z., Keles, E., Yazici, C., Tirkes, T., & Bagci, U. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000966 · Cited by 53
Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers
Bommi, J. R., Kummari, S., Lakavath, K., Sukumaran, R. A., Panicker, L. R., Marty, J., & Goud, K. Y. (2023) · Biosensors · doi:10.3390/bios13030398 · Cited by 52
Farris, M. S., Mosli, M. H., McFadden, A. A., Friedenreich, C. M., & Brenner, D. R. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0301 · Cited by 48
Kumar, A. A., Buckley, B. J., & Ranson, M. (2022) · Biomolecules · doi:10.3390/biom12020152 · Cited by 47
Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
Llop, E., Guerrero, P. E., Duran, A., Barrabés, S., Massaguer, A., Ferri, M. J., Albiol-Quer, M., Llorens, R., & Peracaula, R. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i24.2537 · Cited by 47
Zhao, B., Zhao, B., & Chen, F. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002415 · Cited by 46
Schwartz, N. R. M., Matrisian, L. M., Shrader, E. E., Feng, Z., Chari, S., & Roth, J. A. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7798 · Cited by 43
Listeria monocytogenes: a promising vector for tumor immunotherapy
Ding, Y.-D., Shu, L.-Z., He, R.-S., Chen, K., Deng, Y.-J., Zhou, Z., Xiong, Y., & Deng, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1278011 · Cited by 43
Gupta, N., & Yelamanchi, R. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3158 · Cited by 47
Early detection of pancreatic cancer.
Kim, V. M., & Ahuja, N. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2015.07.03 · Cited by 44
Cannistrà, M., Ruggiero, M., Zullo, A., Serafini, S., Grande, R., & Nardo, B. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2015.04.093 · Cited by 38
Jiang, C., Li, H., Xu, W., & Guo, X. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01635-6 · Cited by 38
Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer
Ying, L., Sharma, A. R., Chhoda, A., Ruzgar, N. M., Hasan, N. M., Kwak, R., Wolfgang, C. L., Wang, T., Kunstman, J. W., Salem, R. R., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001919 · Cited by 37
Lukács, G., Kov́acs, Á., Csanádi, M., Moizs, M., Repa, I., Kaló, Z., Vokó, Z., & Pitter, J. G. (2019) · Cancer Management and Research · doi:10.2147/cmar.s221427 · Cited by 39
Botrus, G., Kosirorek, H., Sonbol, M. B., Kusne, Y. N., Usón, P. L. S., Borad, M. J., Ahn, D. H., Kasi, P. M., Drusbosky, L. M., Dada, H. I., et al. (2021) · The Oncologist · doi:10.1002/onco.13717 · Cited by 36
Pathogenesis of Pancreatic Cancer
Murtaugh, L. C. (2013) · Toxicologic Pathology · doi:10.1177/0192623313508250 · Cited by 40
Alterations of commensal microbiota are associated with pancreatic cancer
Chen, T., Li, X., Li, G., Liu, Y., Huang, X., Ma, W., Qian, C., Jie, G., Wang, S., Qin, Q., et al. (2023) · The International Journal of Biological Markers · doi:10.1177/03936155231166721 · Cited by 33
Nesteruk, K., Levink, I. J. M., de Vries, E., Visser, I. J., Peppelenbosch, M. P., Cahen, D. L., Fuhler, G. M., & Bruno, M. J. (2022) · Pancreatology · doi:10.1016/j.pan.2022.04.010 · Cited by 34
Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer
Rahbari, M., Rahbari, N. N., Reißfelder, C., Weitz, J., & Kahlert, C. (2016) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-016-1468-2 · Cited by 36
BAG3 Is a Novel Serum Biomarker for Pancreatic Adenocarcinomas
Falco, A., Rosati, A., Festa, M., Basile, A. M., Marco, M. D., d’Avenia, M., Pascale, M. C., Piaz, F. D., Tavano, F., di Mola, F. F., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.128 · Cited by 33
Mohamed, A. A., Soliman, H. H., Ismail, M. S., Ziada, D. H., Farid, T. M., Aref, A., Aldaly, M., & Elmageed, Z. Y. A. (2014) · Pancreatology · doi:10.1016/j.pan.2014.10.008 · Cited by 31
Lindquist, C. M., Miller, F. H., Hammond, N., & Nikolaidis, P. (2018) · Abdominal Radiology · doi:10.1007/s00261-017-1308-z · Cited by 4
Omar, A. M., Dibwe, D. F., Tawila, A. M., Sun, S., Phrutivorapongkul, A., & Awale, S. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00735 · Cited by 31
No-touch isolation techniques for pancreatic cancer
Kuroki, T., & Eguchi, S. (2016) · Surgery Today · doi:10.1007/s00595-016-1317-5 · Cited by 30
Lin, M., Alnaggar, M., Liang, S., Chen, J., Xu, K., Dong, S., Du, D., & Niu, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490874 · Cited by 32
Xiong, X., Shi, Q., Yang, X., Wang, W., & Tao, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28209 · Cited by 30
Tang, Y. J., Gao, G., Xia, W.-W., & Wang, J. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110440 · Cited by 30
Moutinho-Ribeiro, P., Iglesias-Garcia, J., Gaspar, R., & Macedo, G. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.027 · Cited by 29
Yoshioka, Y., Shimomura, M., Saito, K., Ishii, H., Doki, Y., Eguchi, H., Nakatsura, T., Itoi, T., Kuroda, M., Mori, M., et al. (2022) · Cancer Science · doi:10.1111/cas.15500 · Cited by 31
High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening
Bruenderman, E. H., & Martin, R. C. G. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.06.046 · Cited by 28
Santos, R. J., Coleman, H. G., Cairnduff, V., & Kunzmann, A. T. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002022 · Cited by 29
Brown, E. G., Canter, R. J., & Bold, R. J. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23812 · Cited by 27
Mustafa, S. A., Pan, L., Marzoq, A. J., Fawaz, M., Sander, L., Rückert, F., Schrenk, A., Hartl, C., Uhler, R., Yildirim, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14449 · Cited by 26
Endoscopic Ultrasound–Based Pancreatic Cancer Screening of High-Risk Individuals
Gangi, A., Malafa, M. P., & Klapman, J. B. (2018) · Pancreas · doi:10.1097/mpa.0000000000001038 · Cited by 27
Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway
Liu, P., Zu, F., Chen, H., Yin, X., & Tan, X. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00390-0 · Cited by 27
Li, H., Li, Y.-D., Cui, L., Wang, B., Cui, W., Li, M., & Cheng, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106566 · Cited by 25
Ariake, K., Motoi, F., Shimomura, H., Mizuma, M., Maeda, S., Terao, C., Tatewaki, Y., Ohtsuka, H., Fukase, K., Masuda, K., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3627-3 · Cited by 25
Chiroptical spectroscopy and metabolomics for blood‐based sensing of pancreatic cancer
Habartová, L., Bunganič, B., Tatarkovič, M., Zavoral, M., Vondroušová, J., Syslová, K., & Setnička, V. (2018) · Chirality · doi:10.1002/chir.22834 · Cited by 24
Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging
Morani, A. C., Hanafy, A. K., Ramani, N. S., Katabathina, V. S., Yedururi, S., Dasyam, A. K., & Prasad, S. R. (2020) · Radiology Imaging Cancer · doi:10.1148/rycan.2020190020 · Cited by 24
Screening for Pancreatic Cancer
Poruk, K. E., Firpo, M. A., & Mulvihill, S. J. (2014) · Advances in Surgery · doi:10.1016/j.yasu.2014.05.004 · Cited by 24
Self-citationA unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma
Sahni, S., Pandya, A., Hadden, W. J., Nahm, C. B., Maloney, S., Cook, V., Toft, J. A., Wilkinson‐White, L. E., Gill, A. J., Samra, J. S., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33368 · Cited by 25
Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer
Peng, C., Li, Z., Huang, L., Gao, W., Wang, J., Li, X., Li, Z., & Yu, X. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.52706 · Cited by 23
The need for effective pancreatic cancer detection and management: a biomarker-based strategy
Crawley, A. S., & O’Kennedy, R. J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1083862 · Cited by 22
Brotherton, L., Welton, M., & Robb, S. W. (2015) · Cancer Medicine · doi:10.1002/cam4.552 · Cited by 23
Imaging and Screening of Pancreatic Cancer
Burk, K. S., Lo, G. C., Gee, M. S., & Sahani, D. V. (2017) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2017.06.006 · Cited by 23
Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
Liu, Z., Hayashi, H., Matsumura, K., Uemura, N., Shiraishi, Y., Sato, H., & Baba, H. (2023) · Cancers · doi:10.3390/cancers15020498 · Cited by 24
Cui, Y., Yuan, Q., Chen, J., Jiang, J. P., Guan, H., Zhu, R., Li, N., Liu, W., & Wang, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1127441 · Cited by 22
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?
Koltai, T. (2023) · Cancers · doi:10.3390/cancers15184430 · Cited by 22
Ariake, K., Motoi, F., Ohtsuka, H., Fukase, K., Masuda, K., Mizuma, M., Hayashi, H., Nakagawa, K., Morikawa, T., Maeda, S., et al. (2017) · Surgery Today · doi:10.1007/s00595-017-1531-9 · Cited by 22
Hata, T., Ishida, M., Motoi, F., Yamaguchi, T., Naitoh, T., Katayose, Y., Egawa, S., & Unno, M. (2016) · Pancreatology · doi:10.1016/j.pan.2016.01.007 · Cited by 21
Pancreatic cancer screening: Still a delusion?
Moutinho-Ribeiro, P., Coelho, R., Giovannini, M. F., & Macedo, G. (2017) · Pancreatology · doi:10.1016/j.pan.2017.07.001 · Cited by 21
Locally advanced pancreatic cancer: An emerging entity
O'Kane, G. M., & Knox, J. J. (2017) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2017.10.006 · Cited by 21
Nasser‐Ghodsi, N., Mara, K. C., & Watt, K. D. S. (2021) · Hepatology · doi:10.1002/hep.31731 · Cited by 21
Tovar, D., Rosenthal, M. H., Maitra, A., & Koay, E. J. (2023) · Artificial Intelligence Surgery · doi:10.20517/ais.2022.38 · Cited by 22
Risk factors of pancreatic cancer and their possible uses in diagnostics
Lang, J., Kunovský, L., Kala, Z., & Trna, J. (2020) · Neoplasma · doi:10.4149/neo_2020_200706n699 · Cited by 20
Metadata
- Authors
- Poruk, K. E., Firpo, M. A., Adler, D. G., & Mulvihill, S. J.
- Affiliations
- University of Utah (US)
- Corresponding author
- Poruk, Katherine E.
- Venue
- Annals of Surgery
- Published
- 2013-01
- Volume
- 257
- Issue
- 1
- Pages
- 17-26
- ISSN
- 0003-4932 (ISSN-L)
- PMC
- PMC4113008
- OpenAlex
- W2050410927
- Cited by
- 249
- References
- 117
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 16 · 2023: 25 · 2022: 33 · 2021: 16 · 2020: 24 · 2019: 25 · 2018: 14 · 2017: 25 · 2016: 18 · 2015: 15 · 2014: 15 · 2013: 4
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T35HL007744)
- National Cancer Institute (U01CA151650, R03CA115225, U01CA15165, R33CA155586, P30CA042014)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- pancreatic cancer, cancer screening, early detection, pancreatic ductal adenocarcinoma, biomarkers, imaging modalities, high-risk groups, risk factors, natural history of disease, resectability, survival
- MeSH terms
- Adenocarcinoma, Humans, Magnetic Resonance Imaging, Pancreatic Neoplasms, Precancerous Conditions, Risk Factors, Sensitivity and Specificity, Tomography, X-Ray Computed, Biomarkers, Tumor, United States, Endosonography, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
